Cirrhotic coagulopathy: A rebalanced hemostasis

Area of Science:

• Hepatology
• Hematology
• Coagulation Science

Background:

• Cirrhosis was traditionally viewed as a hypocoagulable state, increasing bleeding risk.
• However, cirrhotic patients exhibit a high incidence of thrombotic complications, challenging this long-held belief.
• This paradox arises from a simultaneous reduction in both clotting and anticlotting factors, establishing a new hemostatic equilibrium.

Purpose of the Study:

• To review the complex hemostatic changes in cirrhosis.
• To discuss newer diagnostic tests for coagulation assessment in this condition.
• To outline strategies for minimizing coagulopathy before medical procedures.

Main Methods:

• Review of existing literature on cirrhosis and hemostasis.
• Analysis of conventional coagulation tests (e.g., platelet count, prothrombin time).
• Evaluation of newer diagnostic modalities for assessing coagulation status.

Main Results:

• Conventional tests inadequately assess reduced anticoagulation in cirrhosis, leading to an overestimation of bleeding risk.
• Interventions based on conventional tests can inadvertently increase thrombotic risk.
• A new hemostatic equilibrium exists due to decreased clotting and anticlotting factors.

Conclusions:

• The hemostatic system in cirrhosis is complex, involving both procoagulant and anticoagulant factor depletion.
• Relying solely on conventional coagulation tests can be misleading and potentially harmful.
• Accurate assessment and management of coagulopathy are crucial for preventing both bleeding and thrombotic complications in cirrhosis.